Claudia Fredolini

Selectivity analysis of single binder assays used in plasma protein profiling.

Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis.

Immunocapture strategies in translational proteomics.

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease.

PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.

Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence.

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density.

Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease.

Screening a Resource of Recombinant Protein Fragments for Targeted Proteomics.

Systematic assessment of antibody selectivity in plasma based on a resource of enrichment profiles.

Systematic Development of Sandwich Immunoassays for the Plasma Secretome.

CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia.

Bead-Based Assays for Validating Proteomic Profiles in Body Fluids.

Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients.

Microfluidic Device for Patient-Centric Multiplexed Assays with Readout in Centralized Laboratories.

Microneedle Patch for Painless Intradermal Collection of Interstitial Fluid Enabling Multianalyte Measurement of Small Molecules, SARS-CoV-2 Antibodies, and Protein Profiling.

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen.

A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma.

A glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status.